Late coronary stent thrombosis

被引:0
作者
Thuesen, L. [1 ]
Holm, N. R. [1 ]
机构
[1] Aarhus Univ Hosp, Dept Cardiol, DK-8200 Aarhus N, Denmark
关键词
Coronary thrombosis; Stents; Myocardial infarction; DRUG-ELUTING STENTS; BARE-METAL STENTS; TERM CLINICAL-OUTCOMES; MYOCARDIAL-INFARCTION; STANDARD STENT; ARTERY-DISEASE; SLOW-RELEASE; SAFETY; TRIAL; EFFICACY;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Coronary stent thromboses are characterized as early, if they occur within one month of the index PCI. Late stent thromboses (LST) have an occurrence after one month. Both early and late stent thromboses are a major concern in PCI, because of their clinical presentation as acute myocardial infarction and sudden cardiac death. Early stern thromboses are seen following implantation with bare metal (BMS) and drug eluting (DES) stems. Late occurring stein thromboses (LST) are rare but usually severe events and primarily seen after DES implantation. A number of pathogenetic mechanisms seem to be operating and there will probably be major differences between different types DES and the risk of LST. While early stein thrombosis is primarily related to stent implantation techniques, lesion characteristics and the effect of double platelet therapy, there is emerging evidence that very late stent thrombosis, occurring more than one year after the implantation may be caused by local tissue reaction to the polymers of sirolimus and paclitaxel eluting stents. It is likely that the use of new generations DES with tissue friendly polymers or bioabsorbable polymers will reduce the risk of late stent thrombosis.
引用
收藏
页码:25 / 33
页数:9
相关论文
共 45 条
  • [1] A prospective evaluation of the safety and efficacy of the TAXUS Element paclitaxel-eluting coronary stent system for the treatment of de novo coronary artery lesions: Design and statistical methods of the PERSEUS clinical program
    Allocco, Dominic J.
    Cannon, Louis A.
    Britt, Amy
    Heil, John E.
    Nersesov, Andrey
    Wehrenberg, Scott
    Dawkins, Keith D.
    Kereiakes, Dean J.
    [J]. TRIALS, 2010, 11
  • [2] Late thrombosis of drug-eluting stents: A meta-analysis of randomized clinical trials
    Bavry, Anthony A.
    Kumbhani, Dharam J.
    Helton, Thomas J.
    Borek, Przemyslaw P.
    Mood, Girish R.
    Bhatt, Deepak L.
    [J]. AMERICAN JOURNAL OF MEDICINE, 2006, 119 (12) : 1056 - 1061
  • [3] Intracoronary Optical Coherence Tomography: A Comprehensive Review Clinical and Research Applications
    Bezerra, Hiram G.
    Costa, Marco A.
    Guagliumi, Giulio
    Rollins, Andrew M.
    Simon, Daniel I.
    [J]. JACC-CARDIOVASCULAR INTERVENTIONS, 2009, 2 (11) : 1035 - 1046
  • [4] Stent thrombosis late after implantation of first-generation drug-eluting stents - A cause for concern
    Camenzind, Edoardo
    Steg, P. Gabriel
    Wijns, William
    [J]. CIRCULATION, 2007, 115 (11) : 1440 - 1455
  • [5] Randomized Comparison of the Nobori Biolimus A9-Eluting Coronary Stent With the Taxus Liberte Paclitaxel-Eluting Coronary Stent in Patients With Stenosis in Native Coronary Arteries The NOBORI 1 Trial - Phase 2
    Chevalier, Bernard
    Silber, Sigmund
    Park, Seung-Jung
    Garcia, Eulogio
    Schuler, Gerhard
    Suryapranata, Harry
    Koolen, Jacques
    Hauptmann, Karl E.
    Wijns, William
    Morice, Marie-Claude
    Carrie, Didier
    van Es, Gerrit-Anne
    Nagai, Hirofumi
    Detiege, Danny
    Paunovic, Dragica
    Serruys, Patrick W.
    [J]. CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2009, 2 (03) : 188 - U57
  • [6] Two-Year Clinical, Angiographic, and Intravascular Ultrasound Follow-Up of the XIENCE V Everolimus-Eluting Stent in the Treatment of Patients With De Novo Native Coronary Artery Lesions The SPIRIT II Trial
    Claessen, Bimmer E.
    Beijk, Marcel A.
    Legrand, Victor
    Ruzyllo, Witold
    Manari, Antonio
    Varenne, Olivier
    Suttorp, Maarten J.
    Tijssen, Jan G. P.
    Miquel-Hebert, Karine
    Veldhof, Susan
    Henriques, Jose P. S.
    Serruys, Patrick W.
    Piek, Jan J.
    [J]. CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2009, 2 (04) : 339 - 347
  • [7] Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions
    Colombo, A
    Drzewiecki, J
    Banning, A
    Grube, E
    Hauptmann, K
    Silber, S
    Dudek, D
    Fort, S
    Schiele, F
    Zmudka, K
    Guagliumi, G
    Russell, ME
    [J]. CIRCULATION, 2003, 108 (07) : 788 - 794
  • [8] Correlation of Intravascular Ultrasound Findings With Histopathological Analysis of Thrombus Aspirates in Patients With Very Late Drug-Eluting Stent Thrombosis
    Cook, Stephane
    Ladich, Elena
    Nakazawa, Gaku
    Eshtehardi, Parham
    Neidhart, Michel
    Vogel, Rolf
    Togni, Mario
    Wenaweser, Peter
    Billinger, Michael
    Seiler, Christian
    Gay, Steffen
    Meier, Bernhard
    Pichler, Werner J.
    Jueni, Peter
    Virmani, Renu
    Windecker, Stephan
    [J]. CIRCULATION, 2009, 120 (05) : 391 - 399
  • [9] Clinical end points in coronary stent trials - A case for standardized definitions
    Cutlip, Donald E.
    Windecker, Stephan
    Mehran, Roxana
    Boam, Ashley
    Cohen, David J.
    van Es, Gerrit-Anne
    Steg, P. Gabriel
    Morel, Marie-angele
    Mauri, Laura
    Vranckx, Pascal
    McFadden, Eugene
    Lansky, Alexandra
    Hamon, Martial
    Krucoff, Mitchell W.
    Serruys, Patrick W.
    [J]. CIRCULATION, 2007, 115 (17) : 2344 - 2351
  • [10] DAEMEN J, 2007, EUR HEART J, V28, P251